Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
APR Co., Ltd. (278470.KS)
Seoul, KR
APR Co., Ltd., headquartered in Seoul, South Korea, and established in 2014, is a company with a diversified portfolio. It specializes in manufacturing and marketing a broad spectrum of beauty products, catering to both men and women with general cosmetics, as well as more specialized medical skincare solutions. Beyond its core beauty offerings, the company also provides wellness and dietary supplements. Its operations further extend into the realm of electronic beauty devices and an apparel line, primarily retailed through its e-commerce platform. Uniquely, APR Co., Ltd. also manages a network of instant photo booths. Its varied products are sold under prominent brand names including APRILSKIN, medicube, GLAM.D Bio, Forment, and NDY.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -4.02% | -4.37% | -5.17% | +22.17% | +59.19% | +69.10% | +191.64% | +520.47% | +520.47% | +520.47% | +520.47% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-06 | Change |
|---|---|---|
| Strong Buy | 8 | 0 |
| Buy | 18 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Household & Personal Products: +3.3%+111.3% ★ Q1'26: +123.0% (vs Q1'25)
-
EPS growth Household & Personal Products: +8.8%+173.8% ★ Q1'26: +132.9% (vs Q1'25)
-
FCF margin FCF growth · Household & Personal Products: +44.8%+17.5% ★ Q1'26: -0.1% (vs Q1'25)
-
EBIT margin Household & Personal Products: +9.9%+23.9% ★ Q1'26: +24.5% (vs Q1'25)
-
ROIC Household & Personal Products: +8.2%+154,275.3% ★ Q1'26: +201,891.6% (vs Q1'25)
-
Share dilution Household & Personal Products: +0.2%-2.3% ★ Q1'26: +0.8% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Household & Personal Products: -0.51×0.00× Q1'26: 0.00× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 23 Rev. Ana. 22 EPS Ana. |
Dec 2027 26 Rev. Ana. 25 EPS Ana. |
Dec 2028 12 Rev. Ana. 12 EPS Ana. |
|---|---|---|---|---|---|
| Revenue |
722.75B
est: 689.71B (+4.8%)
|
1.53T
est: 1.45T (+5.2%)
|
2.68T
2.49T – 2.89T
+84.8% YoY
|
3.48T
2.82T – 4.13T
+29.8% YoY
|
4.26T
3.68T – 4.85T
+22.4% YoY
|
| EBITDA |
145.00B
est: 123.35B (+17.6%)
|
395.80B
est: 259.76B (+52.4%)
|
479.94B
445.56B – 517.33B
+84.8% YoY
|
622.89B
505.21B – 738.02B
+29.8% YoY
|
762.57B
658.30B – 867.25B
+22.4% YoY
|
| EBIT |
122.51B
est: 105.04B (+16.6%)
|
365.52B
est: 221.21B (+65.2%)
|
408.71B
379.43B – 440.54B
+84.8% YoY
|
530.44B
430.23B – 628.49B
+29.8% YoY
|
649.39B
560.59B – 738.53B
+22.4% YoY
|
| Net Income |
107.59B
est: 94.83B (+13.5%)
|
289.65B
est: 280.50B (+3.3%)
|
528.49B
480.05B – 586.51B
+88.4% YoY
|
701.56B
564.65B – 914.21B
+32.7% YoY
|
876.10B
720.36B – 1.03T
+24.9% YoY
|
| SGA |
396.44B
est: 373.32B (+6.2%)
|
763.61B
est: 786.20B (-2.9%)
|
1.45T
1.35T – 1.57T
+84.8% YoY
|
1.89T
1.53T – 2.23T
+29.8% YoY
|
2.31T
1.99T – 2.62T
+22.4% YoY
|
| EPS |
2,875.00
est: 2,542.04 (+13.1%)
|
7,765.00
est: 7,519.54 (+3.3%)
|
14,167.38
12,868.90 – 15,722.77
+88.4% YoY
|
18,807.09
15,136.83 – 24,507.77
+32.7% YoY
|
23,486.12
19,311.02 – 27,676.97
+24.9% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-06-12 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-06-11 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-06-10 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-06-09 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-06-08 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-06-05 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-06-04 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-06-02 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-06-01 | B | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Kim Byeong Hun | Chairman of the Board & CEO | 3B | male |
| Min-Jun Kang | VP & Finance Manager | 3B | — |
| Yoon-ji Lim | Director | 2B | female |
| Yu-Jin Kim | Vice President | 856M | male |
| Seon-jun Kim | Executive | 734M | — |
| Jae-ha Shin | VP, CFO & Internal Director | 599M | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 278470.KS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
